Although roles for RAGE in NAFLD may be more complex and involve both adaptive and maladaptive cellular consequences, it is plausible that prevention and treatment of the underlying causes, such as obesity, may assuage NAFLD-like conditions and reduce cardiovascular risk (Figure 1). The gene discussed is AGER; the disease is metabolic dysfunction-associated steatotic liver disease.